Most Recent
Maurice Blackburn has filed its promised class action against BHP Billiton over the Brazilian dam collapse, and the case puts a twist on typical funding arrangements, with the law firm looking to earn what it dubs a "litigation services fee" for financing the case itself.
A judge has thrown out the truth defence claimed by the ABC and Fairfax Media in a case brought by Chinese billionaire and philanthropist Dr Chau Chak Wing.
The decision by a federal judge to refuse calls for a confidentiality order keeping under wraps S&P Global's massive class action settlement is a welcome one, experts say, and a preview of judgments to come.
Murray Goulburn and its former CEO appear to be nearing a settlement with the consumer watchdog over claims the dairy producer misled farmers in three states about farmgate milk prices.
AMP has prevailed in a hard-fought fight over where it will defend five shareholder class actions brought in the wake of the Banking Royal Commission, in a precedent-setting judgement that provides a road map for future jurisdictional battles over competing class actions.
The Commonwealth Bank of Australia and other lenders have been warned by the corporate watchdog against a "tick-boxes" approach to reviewing reverse mortgage applications by elderly home owners.
The leader of the notorious cult known as The Family, who is facing a class action by sect members who claim they were tortured and sexually abused as children in her care, has denied the allegations in a bare-bones defence.
A pro bono class action on behalf of asylum seekers who allege they were unlawfully imprisoned in Australian immigration detention centres has been shut down by the Federal Court, which ruled Monday it had no jurisdiction to hear the proceeding.
A Melbourne women who claimed she fell and hurt her right ankle on an international Emirates flight after being denied a glass of water has successfully fought back against the airline's argument that she was not entitled to damages because her injury wasn't serious enough.
US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.